OpenAlex
PricingAboutJobs
Log inGet started
Work

Initial Combination Therapy With Canagliflozin Plus Metformin Versus Each Component as Monotherapy for Drug-Naïve Type 2 Diabetes

HTML

Year: 2016
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetes Care
DOI: 10.2337/dc15-1736
Authors: Julio Rosenstock, Leonard Chuck, Manuel González-Ortiz, Kate Merton, Jagriti Craig, George Capuano, Rong Qiu
Institutions: Medical City Dallas Hospital, Diablo Clinical Research, Universidad de Guadalajara, Janssen Research & Development (United States)
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: type 2 diabetes, canagliflozin, extended-release metformin, SGLT2 inhibitors, combination therapy, monotherapy, initial treatment, HbA1c, glycemic control, weight loss, blood pressure, drug-naive patients, non-inferiority, dose comparison, body weight, fasting blood glucose, adverse events, hypoglycemia, urinary tract infection
SDG: Good health and well-being

Open Access status: closed

Funder: Janssen Research and Development
OpenAlex ID: W2278329651
FWCI: 10.48
Cites: 42
Cited by: 154
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security